Skip Navigation
Skip to contents

Clin Endosc : Clinical Endoscopy

OPEN ACCESS

Articles

Page Path
HOME > Clin Endosc > Volume 53(3); 2020 > Article
CME for
KSGE members
Boost Your Learning With Quiz A Rare Cause of Gastric Subepithelial Tumor
Gwang Ha Kim1,orcid, Do Youn Park2orcid
Clinical Endoscopy 2020;53(3):377-378.
DOI: https://doi.org/10.5946/ce.2020.134
Published online: May 29, 2020

1Department of Internal Medicine, Pusan National University School of Medicine and Biomedical Research Institute, Pusan National University Hospital, Busan, Korea

2St. Mary Pathology Laboratory, Busan, Korea

Correspondence: Gwang Ha Kim Department of Internal Medicine, Pusan National University School of Medicine and Biomedical Research Institute, Pusan National University Hospital, 179 Gudeok-ro, Seo-gu, Busan 49241, Korea Tel: +82-51-240-7869, Fax: +82-51-244-8180, E-mail: doc0224@pusan.ac.kr
• Received: May 16, 2020   • Accepted: May 18, 2020

Copyright © 2020 Korean Society of Gastrointestinal Endoscopy

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • 4,712 Views
  • 144 Download
  • 1 Web of Science
  • 1 Crossref
  • 1 Scopus
prev
A 43-year-old woman presented with a gastric subepithelial tumor incidentally detected during screening endoscopy (Fig. 1A). On follow-up endoscopy 6 months later, the tumor was seen at the posterior wall of the lower body and had increased in size compared with measurements obtained from the previous endoscopy; however, no erosion or ulceration was noted (Fig. 1B). When pressed upon with biopsy forceps, the tumor was found to be hard and unmovable. On endoscopic ultrasonography, the tumor measured 1.5 cm and had a heterogeneously hypoechoic appearance in the deep mucosal and submucosal layers (Fig. 1C). An examination of the specimen obtained from endoscopic biopsy revealed only chronic gastritis. Because the size of the tumor had increased, suggesting malignancy, endoscopic submucosal dissection was performed (Fig. 1D).
What is the most likely diagnosis?
Histopathological examination of the resected specimen revealed spindle tumor cells under myxoid stroma with lymphoplasmacytic infiltration among the tumor cells (Fig. 2A). The spindle cells were immunopositive for smooth muscle actin and vimentin (Fig. 2B) and immunonegative for chromogranin, S-100, C-kit, DOG1, and anaplastic lymphoma kinase (ALK). Based on these findings, a diagnosis of an inflammatory myofibroblastic tumor of the stomach was made. Because the tumor was completely resected with endoscopic submucosal dissection, further treatment was not pursed. No signs of recurrence or metastasis were found during the 18-month follow-up visit.
Inflammatory myofibroblastic tumors are rare mesenchymal tumors with an undetermined behavior that preferentially occur in children and young adults. They most commonly occur in the lungs, mesenteries, omentum, and retroperitoneum [1]. Inflammatory myofibroblastic tumors involving the stomach are extremely rare. The pathogenesis of inflammatory myofibroblastic tumors remains unclear, although various allergic, immunologic, and infectious mechanisms have been postulated [2].
Because gastric inflammatory myofibroblastic tumors localize in the submucosa, endoscopic biopsy usually reveals only chronic gastritis. Thus, surgical resection with adequate margins is the most reliable diagnostic and treatment method. However, as in the present case, endoscopic submucosal dissection can be an alternative diagnostic and treatment modality in selected cases. Although hematogenous metastasis has not been reported, inflammatory myofibroblastic tumors have an intermediate biological potential with frequent local recurrence [3]. Therefore, resection with adequate margins in addition to regular mandatory follow-up to is the best treatment option.
Fig. 1.
(A) Initial endoscopy reveals a small subepithelial tumor at the gastric lower body. (B) On follow-up endoscopy 6 months later, the tumor has increased in size, but no erosion or ulceration is noted. (C) On endoscopic ultrasonography, the tumor is a 1.5 cm-sized, heterogeneously hypoechoic lesion in the deep mucosal and submucosal layers. (D) The resected specimen after endoscopic submucosal dissection.
ce-2020-134f1.jpg
Fig. 2.
(A) Histopathological examination reveals spindle tumor cells under myxoid stroma with lymphoplasmacytic infiltration among the tumor cells (hematoxylin and eosin, ×400). (B) The spindle cells are immunopositive for smooth muscle actin and vimentin, and immunonegative for chromogranin, S-100, C-kit, DOG1, and anaplastic lymphoma kinase (smooth muscle actin, ×200).
ce-2020-134f2.jpg
  • 1. Shi H, Wei L, Sun L, Guo A. Primary gastric inflammatory myofibroblastic tumor: a clinicopathologic and immunohistochemical study of 5 cases. Pathol Res Pract 2010;206:287–291.ArticlePubMed
  • 2. Cook JR, Dehner LP, Collins MH, et al. Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor: a comparative immunohistochemical study. Am J Surg Pathol 2001;25:1364–1371.ArticlePubMed
  • 3. Park SG, Kim GH, Park HJ, Kahng DH, Lee BE, Park DY. [Case of an inflammatory myofibroblastic tumor of the duodenum]. Korean J Gastroenterol 2018;72:28–32.ArticlePubMed

Figure & Data

REFERENCES

    Citations

    Citations to this article as recorded by  
    • A Rare Cause of Subepithelial Tumor in the Gastric Fundus
      Da Mi Kim, Gwang Ha Kim, Kyungbin Kim
      Clinical Endoscopy.2022; 55(2): 313.     CrossRef

    • PubReader PubReader
    • ePub LinkePub Link
    • Cite
      CITE
      export Copy Download
      Close
      Download Citation
      Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

      Format:
      • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
      • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
      Include:
      • Citation for the content below
      A Rare Cause of Gastric Subepithelial Tumor
      Clin Endosc. 2020;53(3):377-378.   Published online May 29, 2020
      Close
    • XML DownloadXML Download
    Figure
    • 0
    • 1
    Related articles
    A Rare Cause of Gastric Subepithelial Tumor
    Image Image
    Fig. 1. (A) Initial endoscopy reveals a small subepithelial tumor at the gastric lower body. (B) On follow-up endoscopy 6 months later, the tumor has increased in size, but no erosion or ulceration is noted. (C) On endoscopic ultrasonography, the tumor is a 1.5 cm-sized, heterogeneously hypoechoic lesion in the deep mucosal and submucosal layers. (D) The resected specimen after endoscopic submucosal dissection.
    Fig. 2. (A) Histopathological examination reveals spindle tumor cells under myxoid stroma with lymphoplasmacytic infiltration among the tumor cells (hematoxylin and eosin, ×400). (B) The spindle cells are immunopositive for smooth muscle actin and vimentin, and immunonegative for chromogranin, S-100, C-kit, DOG1, and anaplastic lymphoma kinase (smooth muscle actin, ×200).
    A Rare Cause of Gastric Subepithelial Tumor

    Clin Endosc : Clinical Endoscopy Twitter Facebook
    Close layer
    TOP